Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-023976
Filing Date
2025-06-27
Accepted
2025-06-27 16:27:23
Documents
1
Period of Report
2025-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5322
  Complete submission text file 0001140361-25-023976.txt   7729
Mailing Address 2901 WEST BLUEGRASS BLVD. SUITE 100 LEHI UT 84043
Business Address 2901 WEST BLUEGRASS BLVD. SUITE 100 LEHI UT 84043 (801) 341-7900
NATURES SUNSHINE PRODUCTS INC (Issuer) CIK: 0000275053 (see all company filings)

EIN.: 870327982 | State of Incorp.: UT | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BUILDING A NO. 1289 YISHAN ROAD SHANGHAI F4 200233
Business Address BUILDING A NO. 1289 YISHAN ROAD SHANGHAI F4 200233 86 21 33987870
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Reporting) CIK: 0001615258 (see all company filings)

State of Incorp.: F4 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34483 | Film No.: 251086754

Mailing Address 104 CARNEGIE CENTER DRIVE SUITE 204 PRINCETON NJ 08540
Business Address 104 CARNEGIE CENTER DRIVE SUITE 204 PRINCETON NJ 08540 609-250-2802
Fosun Pharma USA Inc. (Reporting) CIK: 0002071437 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34483 | Film No.: 251086753